November 8-10, 2021 | Virtual Conference

Register Now en English

PROCESS + PROGRESS

INVALUABLE INFORMATION AND INSIGHTS
ON GENERICS AND BIOSIMILARS

November 8-10, 2021

PROCESS+
PROGRESS

INVALUABLE INFORMATION AND INSIGHTS ON GENERICS AND BIOSIMILARS

November 8-10, 2021

The premier scientific and regulatory event

GRx+Biosims2021 is the premier scientific and regulatory event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals.

THE CONFERENCE YOU NEED – THE CONVENIENCE YOU WANT

GRx+Biosims 2021 will be a virtual conference to keep our community healthy and safe during this public health emergency. Speakers and attendees will be able to join globally from the comfort of their own space. The virtual experience will include showcasing content with keynotes, panel discussions and networking to be fully inclusive to all attendees.

Learn + Connect

Bench scientists and technical professionals can gain insights from drug regulators to help expedite approvals and speed to market, learn about the latest innovation and emerging technology.

Policy professionals, industry professionals and regulators have the opportunity to network with others in the industry and gain a fuller understanding of how regulations affect the real world. In addition, connect with global influencers, increase your knowledge base to stay on the cutting edge and learn about best practices to enhance your organization’s overall performance. 

Learn and Connect

Bench scientists and technical professionals can gain insights from drug regulators to help expedite approvals and speed to market, learn about the latest innovation and emerging technology. 

Policy professionals, industry professionals and regulators have the opportunity to network with others in the industry and gain a fuller understanding of how regulations affect the real world. In addition, connect with global influencers, increase your knowledge base to stay on the cutting edge and learn about best practices to enhance your organization’s overall performance. 

Connect + Share!

Join us at GRx+Biosims 2021 November 8-10, 2021. This conference offers three days of insights and ideas on issues vital to the generic and biosimilar medicines industry. We have put together an ambitious program filled with a range of topics, discussions and views from industry experts.

We look forward to welcoming you at GRx+Biosims 2021.

Connect + Share!

Join us at GRx+Biosims 2021 November 8-10, 2021. This conference offers three days of insights and ideas on issues vital to the generic and biosimilar medicines industry. We have put together an ambitious program filled with a range of topics, discussions and views from industry experts.

We look forward to welcoming you at GRx+Biosims 2021.

Why You
Should Attend

We’ve made it easier now than ever before to be able to attend the conference. No matter where you are physically November 8-10 you will be able to access all the sessions.We’ve made it easier now than ever before to be able to attend the conference. No matter where you are physically November 8-10 you will be able to access all the sessions.

  • Network
    With speakers, attendees, exhibitors and sponsors
  • Get Access
    To the latest information about U.S. generics and biosimilars 
  • Learn
    How the generics and biosimilars industry affects patient outcomes by increasing access to more affordable medicines
  • Make More Informed Decisions
    By better understanding FDA’s expectations
  • Gain Expert Insights
    On the latest regulations, guidance’s, case law and policies
  • Attend
    This one-stop-shop for all your regulatory and scientific needs for the generics and biosimilars industry

Speaker Highlights

The keynote speakers committed to GRx+Biosims 2021 are among our nation’s leading health regulators and authorities.

Janet Woodcock, M.D.

Acting Commissioner, FDA

Read Bio

Jacqueline Corrigan-Curay, JD, M.D.

Principal Deputy Center Director
Center for Drug Evaluation and Research, FDA

Read Bio

Sally Choe, PhD

Director, Office of Generic Drugs,
CDER, FDA

Read Bio

Michael Kopcha, PhD, RPh

Director
Office of Pharmaceutical Quality, CDER, FDA

Read Bio

Donald Ashley, JD

Director
Office of Compliance, CDER, FDA

Read Bio

Sarah Yim, M.D.

Director, Office of Therapeutic
Biologics and Biosimilars,
Office of New Drugs, CDER, FDA

Read Bio

Elizabeth Miller, PharmD

Assistant Commissioner for Medical Products and Tobacco Operations
Office of Regulatory Affairs, FDA

Read Bio

Gerald Dal Pan, M.D., MHS

Director, Office of Surveillance and Epidemiology, CDER, FDA

Read Bio

Sponsorship Opportunities

Raise your company profile by participating in this prestigious event. Included in your sponsorship are custom branded digital assets you can use to promote your sponsorship of the event. You will also gain visibility to your brand through conference advertising prior and during the event.

For more information regarding sponsorship levels and benefits contact Jennifer Soup.

EXPO

Showcase your company at GRx+Biosims 2021.

Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generics and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers.

Attending the GRx+Biosims 2021 conference?

Networking is a big part of this event, and we have all kinds of ready-to-use, simple-to-customize and easy-to-share content that will help you jump-start your networking efforts.

grxbiosims-2021-social-share

Our Sponsors

PLATINUM SPONSOR

GOLD SPONSOR

Apotex Logo

SILVER SPONSORS

BRONZE SPONSORS

Sandoz

PATRON SPONSOR

Sun Pharma Gray Logo-01@2x
LOGO-TARO-RED-2C-01@2x

PUBLICATION PARTNERS

GBI
Skip to content